BGB-15025 Alone and in Combination With Anti-PD-1 Monoclonal Antibody Tislelizumab in Participants With Advanced Solid Tumors

Auckland City Hospital, Auckland

Seoul National University Bundang Hospital, BundangGu SeongnamSi

Harbin Medical University Cancer Hospital, Harbin

Shanghai Pulmonary Hospital, Shanghai

Tianjin Medical University Cancer Institute and Hospital, Tianjin

Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou

Henan Cancer Hospital, Zhengzhou

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

West China Hospital, Sichuan University, Chengdu

Icahn School of Medicine At Mount Sinai, New York

The University of Texas Md Anderson Cancer Center, Houston

Ut Health San Antonio Mays Cancer Center, San Antonio

Prince of Wales Hospital, Randwick

Ashford Cancer Centre Research Northeast, Windsor Gardens

Peter Maccallum Cancer Centre, Melbourne

Linear Clinical Research, Nedlands

Samsung Medical Center, GangnamGu

The Catholic University of Korea, Seoul St Marys Hospital, SeochoGu

Severance Hospital Yonsei University Health System, SeodaemunGu

Asan Medical Center, SongpaGu